325 related articles for article (PubMed ID: 18806277)
1. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
[TBL] [Abstract][Full Text] [Related]
2. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation.
Urayama K; Guilini C; Turkeri G; Takir S; Kurose H; Messaddeq N; Dierich A; Nebigil CG
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):841-9. PubMed ID: 18421008
[TBL] [Abstract][Full Text] [Related]
3. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis.
Urayama K; Guilini C; Messaddeq N; Hu K; Steenman M; Kurose H; Ert G; Nebigil CG
FASEB J; 2007 Sep; 21(11):2980-93. PubMed ID: 17442730
[TBL] [Abstract][Full Text] [Related]
4. Prokineticin receptors in cardiovascular function: foe or friend?
Nebigil CG
Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
[TBL] [Abstract][Full Text] [Related]
5. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
Boulberdaa M; Urayama K; Nebigil CG
Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
[TBL] [Abstract][Full Text] [Related]
6. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
[TBL] [Abstract][Full Text] [Related]
7. Prokineticins and the heart: diverging actions elicited by signalling through prokineticin receptor-1 or -2.
Attramadal H
Cardiovasc Res; 2009 Jan; 81(1):3-4. PubMed ID: 19008213
[No Abstract] [Full Text] [Related]
8. Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart.
Meyer-Kirchrath J; Martin M; Schooss C; Jacoby C; Flögel U; Marzoll A; Fischer JW; Schrader J; Schrör K; Hohlfeld T
Cardiovasc Res; 2009 Feb; 81(2):310-8. PubMed ID: 19019835
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload.
Müller P; Kazakov A; Jagoda P; Semenov A; Böhm M; Laufs U
Cardiovasc Res; 2009 Jul; 83(1):106-14. PubMed ID: 19380417
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
[TBL] [Abstract][Full Text] [Related]
11. Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells.
Müller P; Kazakov A; Semenov A; Böhm M; Laufs U
Cardiovasc Res; 2008 Jan; 77(1):151-9. PubMed ID: 18006457
[TBL] [Abstract][Full Text] [Related]
12. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration.
Guilini C; Urayama K; Turkeri G; Dedeoglu DB; Kurose H; Messaddeq N; Nebigil CG
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H844-52. PubMed ID: 20023120
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
14. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
15. Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disorders.
Boulberdaa M; Turkeri G; Urayama K; Dormishian M; Szatkowski C; Zimmer L; Messaddeq N; Laugel V; Dollé P; Nebigil CG
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):842-50. PubMed ID: 21273561
[TBL] [Abstract][Full Text] [Related]
16. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
[TBL] [Abstract][Full Text] [Related]
17. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
[TBL] [Abstract][Full Text] [Related]
18. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
